Tag: Cancer: Colon
ACG: GLP-1 RAs Tied to Lower Risk for Early-Onset Colorectal Cancer
Findings seen in people with type 2 diabetes
ACG: 2000 to 2022 Saw Rise in Early-Onset CRC Mortality in the United States
Increase in mortality seen in both early- and late-stage tumors
Cell-Free Blood DNA Tests Less Effective Than Other CRC Screening
cf-bDNA costs $89,600 per quality-adjusted life year gained, with alternatives less costly and more effective
FIT Completion, Yield Rates Similar in Those Aged 45 to 49 Versus 50 Years
For individuals aged 45 to 49 years, FIT completion slightly higher while FIT positivity slightly lower
2021 USPSTF Recommendation Boosted Colorectal Cancer Screening
Potential disparities in uptake seen by socioeconomic status and locality among privately insured adults
Omitting 5-FU Bolus Does Not Reduce Survival in Advanced Cancer
However, omission does result in reductions in neutropenia, thrombocytopenia, and use of granulocyte colony-stimulating factor
Breast Cancer Screening Attendance Helps Boost Other Cancer Screenings
Findings seen for women offered self-sampling kits for overdue cancer screenings
Blood Test Results Can Enhance Assessment of Cancer Risk
Blood test results enhance assessment of risk for patients presenting with nonspecific abdominal symptoms
Aspirin-Linked Reduction in CRC Risk Varies With Lifestyle Score
Greater absolute risk reduction seen in those with less healthy lifestyles
Study Looks at Effects of Reducing Intake of Processed Meat, Unprocessed Red Meat
30 percent reduction in processed meat intake would lead to 352,900 fewer occurrences of T2DM, 92,500 fewer occurrences of CVD
